Søgeresultater - Fee Klupp
- Showing 1 - 9 results of 9
-
1
Detailed resolution analysis reveals spatial T cell heterogeneity in the invasive margin of colorectal cancer liver metastases associated with improved survival af Anna Berthel, Inka Zoernig, Nektarios A. Valous, Christoph Kahlert, Fee Klupp, Alexis Ulrich, Juergen Weitz, Dirk Jaeger, Niels Halama
Udgivet 2017Artigo -
2
Serum MMP7, MMP10 and MMP12 level as negative prognostic markers in colon cancer patients af Fee Klupp, Lena Neumann, Christoph Kahlert, Johannes Diers, Niels Halama, Clemens M. Franz, Thomas Schmidt, Moritz Koch, Juergen Weitz, Martin Schneider, Alexis Ulrich
Udgivet 2016Artigo -
3
Invasion front‐specific expression and prognostic significance of microRNA in colorectal liver metastases af Christoph Kahlert, Fee Klupp, Karsten Brand, Felix Lasitschka, Sven Diederichs, Johanna Kirchberg, Nuh N. Rahbari, Shamik Dutta, Ulrich Bork, Johannes Fritzmann, Christoph Reißfelder, Moritz Koch, Juergen Weitz
Udgivet 2011Artigo -
4
Hepatic metastases of colorectal cancer are rather homogeneous but differ from primary lesions in terms of immune cell infiltration af Niels Halama, Anna Spille, Tina Lerchl, Karsten Brand, Esther Herpel, Stefan Welte, Sophia Keim, Bernd Lahrmann, Fee Klupp, Christoph Kahlert, Jürgen Weitz, Niels Grabe, Dirk Jaeger, Inka Zoernig
Udgivet 2013Artigo -
5
Prognostic impact of a compartment-specific angiogenic marker profile in patients with pancreatic cancer af Christoph Kahlert, Maria Fiala, Gabriel Musso, Niels Halama, Sophia Keim, Massimiliano Mazzone, Felix Lasitschka, Mathieu Pecqueux, Fee Klupp, Thomas Schmidt, Nuh N. Rahbari, Sebastian Schölch, Christian Pilarsky, Alexis Ulrich, Martin Schneider, Juergen Weitz, Moritz Koch
Udgivet 2014Artigo -
6
<i>In Silico</i> Modeling of Immunotherapy and Stroma-Targeting Therapies in Human Colorectal Cancer af Jakob Nikolas Kather, Jan Poleszczuk, Meggy Suarez‐Carmona, Johannes Krisam, Pornpimol Charoentong, Nektarios A. Valous, Cleo‐Aron Weis, Luca Tavernar, Florian Leiß, Esther Herpel, Fee Klupp, Alexis Ulrich, Martin Schneider, Alexander Marx, Dirk Jäger, Niels Halama
Udgivet 2017Artigo -
7
Overexpression of ZEB2 at the Invasion Front of Colorectal Cancer Is an Independent Prognostic Marker and Regulates Tumor Invasion <i>In Vitro</i> af Christoph Kahlert, Saleh Lahes, Praveen Radhakrishnan, Shamik Dutta, Carolin Mogler, Esther Herpel, Karsten Brand, Gunnar Steinert, Martin Schneider, Martin Mollenhauer, Christoph Reißfelder, Fee Klupp, Johannes Fritzmann, Christina Wunder, Axel Benner, Matthias Kloor, Cathrin Huth, Pietro Contin, Alexis Ulrich, Moritz Koch, Jürgen Weitz
Udgivet 2011Artigo -
8
CCR5 status and metastatic progression in colorectal cancer af Meggy Suarez‐Carmona, Pornpimol Chaorentong, Jakob Nikolas Kather, Rebecca Rothenheber, Azaz Ahmed, Anna Berthel, Anita Heinzelmann, Rodrigo Rojas Moraleda, Nektarios A. Valous, Zeynep Koşaloğlu, R Eurich, Jana Wolf, Silke Grauling-Halama, Michael Hundemer, Felix Lasitschka, Fee Klupp, Christoph Kahlert, Alexis Ulrich, Martin Schneider, Christine S. Falk, Dirk Jäger, Inka Zoernig, Niels Halama
Udgivet 2019Artigo -
9
Tumoral Immune Cell Exploitation in Colorectal Cancer Metastases Can Be Targeted Effectively by Anti-CCR5 Therapy in Cancer Patients af Niels Halama, Inka Zoernig, Anna Berthel, Christoph Kahlert, Fee Klupp, Meggy Suarez‐Carmona, Thomas Suetterlin, Karsten Brand, Juergen Krauss, Felix Lasitschka, Tina Lerchl, Claudia Luckner‐Minden, Alexis Ulrich, Moritz Koch, Juergen Weitz, Martin Schneider, Markus W. Buechler, Laurence Zitvogel, Thomas Herrmann, Axel Benner, Christina Kunz, Stephan Luecke, Christoph Springfeld, Niels Grabe, Christine S. Falk, Dirk Jaeger
Udgivet 2016Artigo
Søgeredskaber:
Relaterede emner
Cancer
Internal medicine
Medicine
Colorectal cancer
Cancer research
Biology
Immune system
Immunology
Pathology
Biochemistry
Gene
Metastasis
Angiogenesis
CD8
Cancer cell
Cytotoxic T cell
Downregulation and upregulation
Genetics
Granzyme B
In vitro
Oncology
Primary tumor
Surgical oncology
T cell
Tumor microenvironment
Tumor progression
CCL5
CD163
Cancer immunotherapy
Cell